TAO Synergies TAOX
NASDAQ TAOX
$4.14 +0.13 (+3.24%)
As of: Sep 9, 2026 · 11:58 AM EDT

TAO Synergies (TAOX) Gains from Investment Securities (2020 - 2026)

TAO Synergies' (TAOX) quarterly Gains from Investment Securities came in at -$6000.0 in Q2 2026, down 100.04% on a YoY basis from $14.5 million in Q2 2025, and down 200.0% quarter-over-quarter from $6000.0 in Q1 2026.

Analysis

TAO Synergies (TAOX) Gains from Investment Securities (2020 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Gains from Investment Securities for 6 consecutive years, with -$6000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Gains from Investment Securities fell 100.04% year-over-year to -$6000.0; the trailing twelve-month figure through Jun 2026 stood at $5.8 million (down 58.53% YoY), and the FY2025 full-year result was $12.4 million, up 1398.02% from the prior year.
  • Gains from Investment Securities declined to -$6000.0 in Q2 2026 per TAOX's latest filing, from $6000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $14.5 million in Q2 2025 and bottomed at -$8.4 million in Q4 2022.
  • Historically, Gains from Investment Securities has averaged $628329.9 across 5 years, with a median of $0.0 in 2026.
  • The widest YoY moves for Gains from Investment Securities: up 9325.76% in 2025, down 2229.31% in 2025.
  • Over 5 years, Gains from Investment Securities stood at -$8.4 million in 2022, then soared by 96.25% to -$315000.0 in 2023, then soared by 263.49% to $515000.0 in 2024, then slumped by 223.69% to -$637000.0 in 2025, then jumped by 99.06% to -$6000.0 in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods registered -$6000.0, $6000.0, and -$637000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.88 Bn 197.89 Bn 7.24 Bn
2 Gilead Sciences 181.55 Bn 178.37 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.31 Bn 124.45 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn
5 Argenx Se 61.54 Bn 56.36 Bn 1.37 Bn
6 Moderna 54.69 Bn 49.55 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.07 Bn 30.76 Bn 992.69 Mn
8 Biogen 31.41 Bn 30.12 Bn 1.96 Bn
9 Roivant Sciences 30.10 Bn 30.10 Bn 1.16 Mn
10 TAO Synergies 30.93 Mn 30.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6,000.00
Mar 31, 2026 6,000.00
Dec 31, 2025 -637,000.00
Sep 30, 2025 6.40 Mn
Jun 30, 2025 14.52 Mn
Mar 31, 2025 -1.35 Mn
Dec 31, 2024 515,000.00
Sep 30, 2024 218,000.00
Jun 30, 2024 154,000.00
Mar 31, 2024 -58,000.00
Dec 31, 2023 -315,000.00
Sep 30, 2023 -674,000.00
Jun 30, 2023 207,000.00
Mar 31, 2023 -588,000.00
Dec 31, 2022 -8.41 Mn
Mar 31, 2022 71,603.00
Sep 30, 2020 1.70 Mn